1. Home
  2. CLOV vs EVO Comparison

CLOV vs EVO Comparison

Compare CLOV & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clover Health Investments Corp.

CLOV

Clover Health Investments Corp.

HOLD

Current Price

$2.24

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.67

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLOV
EVO
Founded
2014
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
CLOV
EVO
Price
$2.24
$3.67
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$3.35
$7.00
AVG Volume (30 Days)
6.2M
68.7K
Earning Date
02-26-2026
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,773,564,000.00
$887,396,457.00
Revenue This Year
$41.68
N/A
Revenue Next Year
$43.92
$8.52
P/E Ratio
N/A
N/A
Revenue Growth
32.15
N/A
52 Week Low
$2.12
$2.84
52 Week High
$4.80
$4.80

Technical Indicators

Market Signals
Indicator
CLOV
EVO
Relative Strength Index (RSI) 36.71 56.52
Support Level $2.45 $3.53
Resistance Level $2.73 $3.81
Average True Range (ATR) 0.14 0.08
MACD -0.04 0.00
Stochastic Oscillator 5.22 54.17

Price Performance

Historical Comparison
CLOV
EVO

About CLOV Clover Health Investments Corp.

Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: